Federal Supply Schedule 36F79726D0058
Award Date 1/1/26
Last Date to Order 12/31/30
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Neurotech Pharmaceuticals, Inc. The contract, which has a ceiling value of $25,000.00 and a period of performance through December 31, 2025, is an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. As a multiple award Federal Supply Schedule contract, it allows...
- Intra-Cellular Therapies, Inc. (UEI: VA5JXLCJHDK7) was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on October 1, 2020, with an ultimate completion date of September 30, 2026. This multiple-award contract, funded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency component of the Department of Veterans Affairs, carries a ceiling value of $24,000,000. The contract was issued on a non-set-aside basis and includes a...
- Supernus Pharmaceuticals, Inc. (UEI: YGWZHL8KYAM8) was awarded a Federal Supply Schedule 65-IB multiple award contract on September 15, 2022, by Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, with a ceiling value of $132.6 million and an ultimate completion date of September 14, 2027, establishes a vehicle for the supply of drugs, pharmaceuticals, and hematology-related products to Veterans Affairs medical facilities and...
- Bioxcel Therapeutics, Inc. (UEI: KRNFT2F99W76) was awarded a multiple award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, awarded on February 15, 2023, carries a ceiling value of $2,225,000 and is set to expire on February 14, 2028. This General Services Administration schedule contract establishes a framework for the supply of...
- ONY Biotech Inc. (UEI: L3ZJABL49BB8) was awarded a multiple-award Federal Supply Schedule contract on March 15, 2017, for the provision of drugs, pharmaceuticals, and hematology-related products under General Services Administration schedule 65 IB. The indefinite delivery vehicle carries a ceiling value of $294,760.00 and remains effective through March 14, 2026. The contract incorporates Public Law 102-585 pricing provisions with dual pricing structures and was awarded without set-asides. The...
- Acrotech Biopharma Inc. (UEI: DN63NKTYLF33) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule on February 15, 2020, to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract carries a ceiling value of $225,000 and extends through February 14, 2026. This Federal Supply Schedule contract...
- This Federal Supply Schedule contract, awarded to Neurelis Inc. (UEI: LHACH46DW2N1) on August 15, 2021, establishes a multiple-award indefinite delivery vehicle for the procurement of pharmaceuticals, drugs, and hematology-related products under General Services Administration schedule 61-IB. The contract carries a ceiling value of $7.41 million and operates through August 14, 2026. The funding agency is Veterans Integrated Service Network 12, a civilian component of the Department of Veterans...
- Sarfez Pharmaceuticals, Inc. (UEI: YRJBXMC3Y9W6) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, awarded on August 1, 2022, has a ceiling value of $435,680.00 and carries an ultimate completion date of July 31, 2027. This indefinite delivery vehicle operates without a set-aside restriction, allowing...
- Nuvation Bio, Inc. (UEI: ZF4GX9YEQE24) has been awarded a Federal Supply Schedule multiple-award contract by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract, effective December 15, 2025, through December 14, 2030, carries a ceiling value of $619,248.00 and covers pharmaceutical products and services under Federal Supply Schedule category 65 I B, which encompasses drugs, pharmaceuticals, and hematology-related...
- Verona Pharma, Inc. (UEI: JB17M46E2YS9) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. This contract award, effective March 15, 2025, covers drugs, pharmaceuticals, and hematology-related products and services under Federal Supply Group 65, Item Class 1B. The contract carries a ceiling value of...